section name header

Introduction ⬇

ICD codes ⬆ ⬇

ICD-10: L88

Epidemiology ⬆ ⬇

Rare, prevalence unknown. All age groups affected with a peak between 40 and 60 years. Slight preponderance of females.

Etiology and Pathogenesis ⬆ ⬇

Unknown. Although called pyoderma, it does not have a microbial etiology. Pyoderma gangrenosum (PG) is counted among the neutrophilic dermatoses because of the massive neutrophilic infiltrates within the skin. It may belong to the autoinflammatory disease spectrum.

Clinical Manifestation ⬆ ⬇

THREE TYPESAcute: Acute onset with painful hemorrhagic pustule or painful nodule either de novo or after trauma. There is the phenomenon of pathergy, where a needle prick, insect bite, biopsy, or other minimal trauma can trigger a lesion. Chronic: Slow progression with granulation and hyperkeratosis. Less painful. Bullous: True blisters often hemorrhagic and associated with hematologic disease.

SKIN LESIONSAcute: Superficial hemorrhagic pustule surrounded by erythematous halo; very painful (Fig. 7-1). Breakdown occurs with ulcer formation, whereby ulcer borders are dusky-red or purple, irregular and raised, undermined, and boggy with perforations that drain pus (Fig. 7-2). The base of the ulcer is purulent with hemorrhagic exudate, partially covered by necrotic eschar (Fig. 7-3), with or without granulation tissue. Pustules both at the advancing border and in the ulcer base; a halo of erythema spreads centrifugally at the advancing edge of the ulcer (Fig. 7-3). Chronic: Lesions may slowly progress, grazing over large areas of the body and exhibiting massive granulation within the ulcer from the outset (Fig. 7-4) with crusting and even hyperkeratosis on the margins (Fig. 7-5). Lesions are usually solitary but may be multiple and form clusters that coalesce. Most common sites: Lower extremities (Figs. 7-2 and 7-5) > buttocks > abdomen (Fig. 7-3) > face (Fig. 7-4). Healing of ulcers results in thin atrophic cribriform scars. Bullous: Blisters from the outset, often hemorrhagic, followed by ulceration.

MUCOUS MEMBRANES Rarely, aphthous stomatitis-like lesions; very rarely massive ulceration of oral mucosa and conjunctivae.

General Examination

Patient appears ill.

Associated Systemic Diseases

Up to 50% of cases occur without associated disease. The remainder of cases are associated with arthritis, large- and small-bowel disease (Crohn disease and ulcerative colitis), diverticulosis (diverticulitis), paraproteinemia and myeloma, leukemia, autoimmune hepatitis, Behçet syndrome (which is also a disease with pathergy).

Laboratory Examinations ⬆ ⬇

There is no single diagnostic test.

ESR Variably elevated.

DERMATOPATHOLOGY Not diagnostic. Neutrophilic inflammation with abscess formation and necrosis.

Diagnosis and Differential Diagnosis ⬆ ⬇

Clinical findings plus history and course; confirmed by compatible dermatopathology. Differential diagnosis: Ecthyma and ecthyma gangrenosum, atypical mycobacterial infection, clostridial infection, deep mycoses, amebiasis, leishmaniasis, bromoderma, pemphigus vegetans, stasis ulcers, and granulomatous vasculitis.

Course and Prognosis ⬆ ⬇

Untreated, course may last months to years, but spontaneous healing can occur. Ulceration may extend rapidly within a few days or slowly. Healing occurs centrally with peripheral extension. New ulcers may appear as older lesions resolve. Pathergy.

Management ⬆

WITH ASSOCIATED UNDERLYING DISEASE Treat underlying disease.

SYSTEMIC TREATMENT High doses of oral glucocorticoids or IV glucocorticoid pulse therapy (1 to 2 mg/kg) may be required. Cyclosporine can also be considered as a first-line treatment for severe disease. Second-line and adjunctive treatment options include TNF-alpha inhibitors, mycophenolate mofetil, methotrexate, azathioprine, and dapsone.

TOPICAL Local disease can be treated with topical and intralesional steroids.